InternationalUSRemember you can easily switch between MIP US and MIP International at any time

UPC scenario 2: a blockbuster drug patent with an SPC

Managing Intellectual Property


In our second discussion of a hypothetical UPC scenario, Duncan Ribbons and Rebecca Lawrence address some of the complications that arise with SPCs, licences, opt outs and injunctions

The Unified Patent Court (UPC) promises to herald a new dawn for patent litigation in Europe. Pan-European injunctions and central revocation will become normal, whereas under the current system injunctions and revocations must be obtained on a country-by-country basis. However, patentees will be able to choose not to participate in the new system, for example if the risk of central revocation out weights the benefits of central enforcement, and this is one of the biggest issues that requires immediate attention....


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

UK: Increasing the PACE at the EPO (sponsored) https://t.co/rlMDTJqb37

Jul 27 2016 01:31 ·  reply ·  retweet ·  favourite
ManagingIP profile

Spain: The utility model alternative (sponsored) https://t.co/pnrQde7nFI

Jul 27 2016 11:25 ·  reply ·  retweet ·  favourite
ManagingIP profile

Belgium: Changes following the new EU Trade Mark Directive (sponsored) https://t.co/QuzXN4TyNT

Jul 27 2016 09:15 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


Mid Year 2016

All eyes on ASEAN

Economic and legal reforms are driving harmonisation within and beyond the ASEAN region, with big implications for IP owners. James Nurton, Stephy Tang and Natalie Rahhal introduce a year-long series of articles



Most read articles

Supplements